Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Neuro Protective Effect of N6- Isopentanyl Adenosine

Neuro Protective Effect of N6- Isopentanyl Adenosine

Parul Ramkrishnan, Anand Vijayakumar
Shinde, Sangmeshwar Baburao
Gupta, Kumari Sonal

Paperback

Medical Reference

ISBN10: 6209096492
ISBN13: 9786209096495
Publisher: LAP Lambert Academic Publishing
Published: Apr 23 2026
Pages: 76
Weight: 0.25
Height: 0.18 Width: 6.00 Depth: 9.00
Language: English
Alzheimer's disease (AD), the most prevalent form of dementia, is a progressive neurodegenerative disorder that affects millions, particularly in the aging population. Characterized by senile plaques, amyloid-beta (Aβ) deposits, neurofibrillary tangles, and selective neuronal loss, AD leads to a gradual decline in cognitive function, memory, and daily functioning. While current treatments primarily target symptomatic relief by modulating neurotransmitter levels, they do little to halt the disease's progression.N6-Isopentyladenosine (iPA), a naturally occurring purine derivative, holds promise as a novel therapeutic approach in neurodegenerative diseases like Alzheimer's. With its remarkable anti-inflammatory, antioxidant, and anti-apoptotic properties, iPA has been shown to modulate key signaling pathways that promote neuronal survival and plasticity. Preclinical studies have demonstrated its potential to reduce inflammation, attenuate neuronal damage, and improve cognitive function in animal models, offering new hope for AD patients.

Also from

Parul Ramkrishnan, Anand Vijayakumar

View All

Also in

Medical Reference

View All